...
【24h】

Prescription Drug Monitoring Programs: Ethical Issues. in the Emergency Department

机译:处方药监测计划:道德问题。 在急诊部门

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Prescription drug monitoring programs are statewide databases available to clinicians to track prescriptions of controlled medications. These programs may provide valuable information to assess the history and use of controlled substances and contribute to clinical decisionmaking in the emergency department (ED). The widespread availability of the programs raises important ethical issues about beneficence, nonmaleficence, respect for persons, justice, confidentiality, veracity, and physician autonomy. In this article, we review the ethical issues surrounding prescription drug monitoring programs and how those issues might be addressed to ensure the proper application of this tool in the ED. Clinical decisionmaking in regard to the appropriate use of opioids and other controlled substances is complex and should take into account all relevant clinical factors, including age, sex, clinical condition, medical history, medication history and potential drug-drug interactions, history of addiction or diversion, and disease state.
机译:处方药监测计划是临床医生可用于跟踪受控药物的处方的全州数据库。这些计划可以提供有价值的信息,以评估受控物质的历史和使用,并有助于急诊部门(ED)的临床决策。该计划的广泛可用性提出了关于益智,非公法,尊重人员,正义,保密性,准确性和医生自主权的重要道德问题。在本文中,我们审查了处方药监测计划的道德问题以及如何解决这些问题,以确保适当在ED中应用此工具。关于适当使用阿片类药物和其他受控物质的临床决策是复杂的,并应考虑所有相关的临床因素,包括年龄,性别,临床状况,病史,药物历史和潜在的药物 - 药物相互作用,成瘾史或转移和疾病状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号